Gérard Soula

Founder bei ADOCIA

Vermögen: 10 Mio $ am 31.03.2024

78 Jahre

Health Technology

Consumer Services

Technology Services

Aktive Positionen von Gérard Soula

Unternehmen	Position	Beginn	Ende
ADOCIA	Chairman	24.02.2012	-
	Founder	16.12.2005	-
	Director/Board Member	24.10.2011	24.02.2012
	Chief Executive Officer	16.12.2005	11.05.2023
	President	16.12.2005	11.05.2023
GLOWBL SAS GLOWBL SAS Packaged SoftwareTechnology Services GLOWBL SAS designs and develops communications software for videoconferencing and content sharing. It enables users to share media content and live events. The company was founded in 2011 and is headquartered in Lyon, France.	Director/Board Member	-	-

Unternehmen	Position	Beginn	Ende
Flamel Technologies SA Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Flamel Technologies SA engages in the research, development and commercialization of pharmaceutical products. Its portfolio includes Bloxiverz, Vazculep, Micropump, LiquiTime, Trigger Lock and Medusa. The company was founded by Gérard Soula in August 1990 and is headquartered in Vénissieux, France.	Chairman	01.08.1990	01.01.2005
	Chief Tech/Sci/R&D Officer	01.08.1990	01.06.2005
	Founder	01.08.1990	01.01.2005
	President	01.08.1990	01.01.2005
Life Cycle Pharma A/S	Director/Board Member	-	-
VELOXIS PHARMACEUTICALS A/S	Director/Board Member	01.11.2005	-

Université d'Aix-Marseille

Doctorate Degree

International

Frankreich	5
Dänemark	3

Operativ

Sektoral

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	1
ADOCIA	Health Technology

Private Unternehmen	4
Flamel Technologies SA Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Flamel Technologies SA engages in the research, development and commercialization of pharmaceutical products. Its portfolio includes Bloxiverz, Vazculep, Micropump, LiquiTime, Trigger Lock and Medusa. The company was founded by Gérard Soula in August 1990 and is headquartered in Vénissieux, France.	Health Technology
Veloxis Pharmaceuticals A/S Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Veloxis Pharmaceuticals A/S is a commercial-stage specialty pharmaceutical company, which engages in the development and commercialization of medicine for the prevention of organ rejection in kidney transplant patients. The company is focused on the direct commercialization of Envarsus XR in the US, expansion of partnerships for markets, and acquisition of assets utilized in transplant patients and by adjacent medical specialties. Veloxis Pharmaceuticals was founded in June 2002 and is headquartered in Copenhagen, Denmark.	Health Technology
Life Cycle Pharma A/S
GLOWBL SAS GLOWBL SAS Packaged SoftwareTechnology Services GLOWBL SAS designs and develops communications software for videoconferencing and content sharing. It enables users to share media content and live events. The company was founded in 2011 and is headquartered in Lyon, France.	Technology Services